The sensor and adhesive patch were returned, and a visual inspection was completed, no issues were identified.The product was forwarded to extended investigation.The investigation conducted indicates that both the applicator and sharp passed all tests and met all specifications prior to release.Dose audit reports were reviewed and demonstrated the continued effectiveness of the established sterilization process for libre sensor products.Environmental monitoring reports were reviewed, including bioburden and endotoxin testing, which demonstrated that all monitoring processes continue to meet adc requirements.Thus, this complaint is not confirmed.The date of event is unknown.The date entered is the date abbott diabetes care became aware of the event.All pertinent information available to abbott diabetes care has been submitted.
|
An hcp reported a customer had an adverse skin reaction while wearing the adc freestyle libre pro sensor and experienced a rash and soreness at the sensor site.Hcp contact was made and the customer was prescribed the antibiotic "t- bact (mupirocin) and the steroid, betnovate (betamethasone) ointment, as treatment.There was no report of death or permanent injury associated with this event.
|